C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/09/2004	US20040247601 Methods for diagnosing cancer and decreasing metastasis by cancer cells
12/09/2004	US20040247600 Agent that specifically binds to human MTAP protein in an embedded biological sample, especially a polyclonal antibody or a monoclonal antibody produced by hybridoma cell line ATCC Accession No. PTA-5001
12/09/2004	US20040247599 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
12/09/2004	US20040247598 In particular of delayed-type hypersensitivity; especially administering an IL-18 binding protein or a derivative, an expression vector or a genetically engineered cell, optionally with an antiinflammatory agent such as a COX-inhibitor.
12/09/2004	US20040247597 Method of treating atherosclerosis and other inflammatory diseases
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247594 Activating T lymphocytes of several to all sub-groups without an occupation of an antigen receptor of the lymphocytes; for use in treating granulocytopenia, thrombocytopenia, aplastic anemias or bone marrow failures with aplasia/hypoplasia of the bone marrow and pancytopenia
12/09/2004	US20040247593 Inhibiting the growth of a cancer cell that overexpresses a Wnt protein by contacting the cell with an agent that inhibits binding of the Wnt protein to a Frizzled receptor; screening for an agent inhibits cancer cell proliferation by contacting the agent with a Dvl protein or nucleic acid
12/09/2004	US20040247591 administering a humanized or chimeric antibody that specifically binds to an epitope within A beta 3-6, A; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease.
12/09/2004	US20040247590 Prevention and treatment of amyloidogenic disease
12/09/2004	US20040247589 More particularly from the serum of alligators or crocodiles; active proteins obtained from the sera show no overt toxicity in healthy mammals, and may therefore be used for the prevention, investigation, treatment or diagnosis of cancer
12/09/2004	US20040247588 Lyophilizing a solution of a modified antibody (especially Certolizumab Pegol) containing molecules capable of adversely affecting the stability or solubility of the antibody after lyophilization and from which some of those moledules have been removed
12/09/2004	US20040247585 Recombinant alpha-galactosidase a therapy for fabry disease
12/09/2004	US20040247564 Treating a tissue disorder involving a loss and/or apoptosis of cells by administering an agent that induces phosphorylation and/or activation of protein kinase B to cause proliferation; particularly administering a human stromal-derived factor-1 and a G-CSF to cause proliferation of cardiomyocytes
12/09/2004	US20040247562 Diagnostic and prognostic method for cancer based on skipping of the exon 3 region of the G-CSF gene at mRNA or protein levels
12/09/2004	DE10322044A1 Thioredoxin-Peroxidase von C. albicans als virulenzspezifischer Marker Thioredoxin peroxidase of C. albicans as virulenzspezifischer marker
12/09/2004	CA2527795A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/09/2004	CA2527694A1 Fab library for the preparation of anti vegf and anti rabies virus fabs
12/09/2004	CA2527571A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004	CA2526623A1 Soluble clca-1 and antagonists to clca-1
12/09/2004	CA2526546A1 Methods for producing antibodies
12/09/2004	CA2525717A1 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	CA2525540A1 Enterococcus antigens
12/09/2004	CA2523716A1 Human anti-human cd3 binding molecules
12/09/2004	CA2522894A1 Pharmaceutical composition comprising a bispecific antibody specific for epcam
12/09/2004	CA2522586A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
12/09/2004	CA2519835A1 Method of treating corneal transplant rejection
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484398A1 Human glioma antigen originating in testis
12/08/2004	EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division
12/08/2004	EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth
12/08/2004	EP1484336A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/08/2004	EP1484063A2 Method for inhibiting rejection of transplanted tissue
12/08/2004	EP1483415A2 A non-invasive diagnostic test utilizing histone modification markers
12/08/2004	EP1483408A1 Nanostructures containing pna joining or functional elements
12/08/2004	EP1483407A2 Methods of therapy and diagnosis
12/08/2004	EP1483397A2 Oligomeric molecules and uses thereof
12/08/2004	EP1483389A2 Genetic products differentially expressed in tumors and use thereof
12/08/2004	EP1483384A2 Method for overexpression of zwitterionic polysaccharides
12/08/2004	EP1483383A2 Methods anc compositions for in vivo clearance of pathogens
12/08/2004	EP1483381A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
12/08/2004	EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
12/08/2004	EP1483296A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
12/08/2004	EP1483295A2 Rs7 antibodies
12/08/2004	EP1483294A2 Internalizing anti-cd74 antibodies and methods of use
12/08/2004	EP1483293A2 Use of an active substance that binds to cd28 for producing a pharmaceutical composition
12/08/2004	EP1483292A1 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482981A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
12/08/2004	EP1482975A2 Prevention of tissue adhesion
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482964A1 Use of egfr transactivation inhibitors in human cancer
12/08/2004	EP1404428A4 Methods for purifying highly anionic proteins
12/08/2004	EP1143797A4 Methods for reducing adverse side effects associated with cellular transplantation
12/08/2004	EP1125135B1 A complex of a chaperone with beta-amyloid and methods employing this complex
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	EP0966535B1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/08/2004	CN1554026A Prognostic indicator
12/08/2004	CN1553956A Novel genetic products of ashbya gossypii, associated with transmembrane transport
12/08/2004	CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
12/08/2004	CN1552857A Brewer's yeast recombined hepatitis B virus surface antigen stream plus addition femrentation
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552736A Monoclone antibody against HnRNP A2/B1 antigen, its preparation and use
12/08/2004	CN1552735A Engineering antibody against CD44 for inducing leukemia cell differentation and necrosis
12/08/2004	CN1552730A SARS early diagnostic method and reagent box
12/08/2004	CN1552729A SARS early diagnostic method and reagent box
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178952C Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
12/08/2004	CN1178950C Corpuscles of stannius protein and stanniocalcin
12/07/2004	US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
12/07/2004	US6828422 Protein/(poly)peptide libraries
12/07/2004	US6828420 Small conductance, calcium-activated potassium channels (SKI)
12/07/2004	US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
12/07/2004	US6828416 Recombinant multivalent malarial vaccine against Plasmodium falciparum
12/07/2004	US6828123 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004	US6828122 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004	US6828114 Monoclonal antibody against apolipoprotein A-I
12/07/2004	US6828110 Assays for detection of Bacillus anthracis
12/07/2004	US6827960 Cross flow membrane filtration recovering nutraceuticals without recirculation of chromatographic resins or casein preprecipitation; minimizing waste
12/07/2004	US6827948 Method and compositions for processing poultry feathers
12/07/2004	US6827936 Glucosyltransferase subunits; radially branched macromolecular structure with peptidyl core matrix comprised of at least lysine, arginine and histidine
12/07/2004	US6827934 Autoimmune and infectious diseases, transplant rejection, inflammatory disorders; reduced immunogenicity
12/07/2004	US6827925 Specific binding proteins including antibodies which bind to the necrotic center of tumors, and uses thereof
12/07/2004	CA2217776C Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/07/2004	CA2208673C Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
12/02/2004	WO2004104598A1 Diagnostic kit for liver cirrhosis compring an antibody specific for human protooncogenic protein
12/02/2004	WO2004104597A1 Method for the prediction, diagnosis and differential diagnosis of alzheimer's disease
12/02/2004	WO2004104173A2 Ovr115 ANTIBODY COMPOSITION AND METHODS OF USE
12/02/2004	WO2004104046A1 Production of recombinant igm in per.c6 cells
12/02/2004	WO2004104045A1 Therapeutical use of anti-cd70 antibody for treating or preventing aids
12/02/2004	WO2004104044A1 Process for producing antibody
12/02/2004	WO2004104038A1 Control of the intracellular localization of ip3 receptor
12/02/2004	WO2004103405A1 Servere acute respiratory syndrome associated antibodies and method for detecting them and use thereof
12/02/2004	WO2004103404A1 Cd20 binding molecules
12/02/2004	WO2004103403A1 Immunocompetent cell activation inhibitor and use thereof
12/02/2004	WO2004103294A2 Methods and compositions for the prevention and treatment of sepsis

1 ... 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 ... 1494